Asia-Pacific Interventional Oncology Market Overview:
The Asia-Pacific Interventional Oncology Market estimated at 428.64 million USD in 2018 and is expected to reach 774.00 million USD by 2025, growing at a compound annual rate of 8% over the 2018-2025 forecast period.
Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures performed by interventional radiologists for the diagnosis, treatment and palliation of different types of cancer. In interventional oncology procedures, various image-guided techniques are used, such as computed tomography, fluoroscopy and ultrasound to diagnose and treat the specific site affected by pain or cancer.
Browse details of 140 number of pages research report developed on Asia-Pacific Interventional Oncology Market Research Report @ https://www.researchcosmos.com/reports/asia-pacific-interventional-oncology-market/44785236
Interventional oncology is used to treat primary or metastatic cancers such as liver cancer, kidney cancer, lung cancer, prostate cancer, breast cancer and pancreatic cancer. Most of these procedures are performed on an outpatient basis or require to spend the night in the hospital. Some of the popular procedures are pain relief, intra-arterial therapy, and abstinence therapy and neoadjuvant procedures.
Drivers, Challenges and Opportunities – Asia-Pacific Interventional Oncology Market:
Minimally invasive techniques have been widely used to treat cancer cells better than anticancer treatments such as radiotherapy, surgery and daily chemotherapy. The growing demand for minimally invasive therapies has become a key driver of market growth. This procedure can also be used to treat other related complications and inoperable patients. In addition, health professionals and patients are progressively adopting minimally invasive procedures in interventional oncology because of the benefits of such techniques like the reducing length of hospital stay, minimizing risk of infection, shortened risk of complication, quick pain relief and rapid recovery. These advantages, when using minimally invasive procedures, will promote the growth of the Asia Pacific market for interventional oncology.
Ask Free Sample of the Report @ https://www.researchcosmos.com/request/asia-pacific-interventional-oncology-market/44785236
Geographic Segmentation:
It is anticipated that the Asia-Pacific interventional oncology market will achieve a high CAGR during the forecast period due to the high prevalence of cancer in highly populated countries of India and China, rapidly changing health, several government initiatives to improve health care in general, and increase in health spending per capita. In addition, it is likely that increased investment by leading global oncology interventional device companies in the region will contribute to the growth of this market during the forecast period.
Key market players:
Some of the key players in the Asia Pacific interventional oncology market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BTG plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson & Johnson), Merit Medical Systems, Inc. and Sirtex Medical Limited, Siemens Healthineers, Eckert & Ziegler BEBIG, Varian Medical Systems, Inc., HealthTronics, Inc, etc.
For any queries, inquire more @ https://www.researchcosmos.com/inquire/asia-pacific-interventional-oncology-market/44785236
About Us:
Research Cosmos is a provider of standard and customized Industry research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending Industry reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Media Contact
Company Name: Research Cosmos
Contact Person: Kevin Stewart
Email: Send Email
Phone: 1-888-709-8757
Address:4390 U.S 1, Suite 211
City: Princeton
State: New Jersey
Country: United States
Website: https://www.researchcosmos.com/reports/asia-pacific-interventional-oncology-market/44785236